Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
23.60
-0.39 (-1.63%)
Jul 15, 2025, 4:00 PM - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 71 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 6.07%, Boston Scientific at 5.45%, Alnylam Pharmaceuticals at 3.80%, Danaher at 3.56%, and Veeva Systems at 3.52%.
Total Holdings
71
Top 10 Percentage
38.28%
Asset Class
Equity
ETF Category
Health
Assets
52.98M
PE Ratio
41.33
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Fidelity Securities Lending Cash Central Fund | 6.07% |
| 2 | BSX | Boston Scientific Corporation | 5.45% |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.80% |
| 4 | DHR | Danaher Corporation | 3.56% |
| 5 | VEEV | Veeva Systems Inc. | 3.52% |
| 6 | PODD | Insulet Corporation | 3.28% |
| 7 | ARGX | argenx SE | 3.23% |
| 8 | WAY | Waystar Holding Corp. | 3.15% |
| 9 | LEGN | Legend Biotech Corporation | 3.12% |
| 10 | ISRG | Intuitive Surgical, Inc. | 3.09% |
| 11 | EXAS | Exact Sciences Corporation | 3.03% |
| 12 | EBR: UCB | UCB SA | 2.95% |
| 13 | PEN | Penumbra, Inc. | 2.81% |
| 14 | MASI | Masimo Corporation | 2.62% |
| 15 | SYK | Stryker Corporation | 2.55% |
| 16 | EW | Edwards Lifesciences Corporation | 2.52% |
| 17 | EPA: DIM | Sartorius Stedim Biotech S.A. | 2.33% |
| 18 | LLY | Eli Lilly and Company | 1.93% |
| 19 | DXCM | DexCom, Inc. | 1.89% |
| 20 | INSP | Inspire Medical Systems, Inc. | 1.73% |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | 1.71% |
| 22 | LFST | LifeStance Health Group, Inc. | 1.66% |
| 23 | UNH | UnitedHealth Group Incorporated | 1.61% |
| 24 | TMO | Thermo Fisher Scientific Inc. | 1.57% |
| 25 | RMD | ResMed Inc. | 1.55% |
As of Jul 11, 2025